StockData
Jaguar Health, Inc. logo

Jaguar Health, Inc. (JAGX) stock

JAGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$0.35−0.03 (-7.03%)

Close on Nov 18, 2026Market cap $1.83MP/E –Yield –

Jaguar Health revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Jaguar Health's revenue for the twelve months ending Jun 30, 2026 was $27.82M, up 135.5% year over year. For fiscal 2025 it was $11.51M, down 1.5% from the year before. Over ten years it grew 46.2% a year on average. The highest annual figure on record is $11.96M in fiscal 2022.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$11.51M-1.5%
FY2024Dec 31, 2024$11.69M+19.8%
FY2023Dec 31, 2023$9.76M-18.4%
FY2022Dec 31, 2022$11.96M+175.8%
FY2021Dec 31, 2021$4.34M-53.8%
FY2020Dec 31, 2020$9.39M+62.5%
FY2019Dec 31, 2019$5.78M+30.8%
FY2018Dec 31, 2018$4.42M+1.3%
FY2017Dec 31, 2017$4.36M+2981.6%
FY2016Dec 31, 2016$141.52K-45.2%
FY2015Dec 31, 2015$258.38K–
FY2014Dec 31, 2014$0–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.23M-58.9%
Q1 FY2026Mar 31, 2026$20.27M+815.6%
Q4 FY2025Dec 31, 2025$3.24M-7.8%
Q3 FY2025Sep 30, 2025$3.08M-0.8%
Q2 FY2025Jun 30, 2025$2.98M+9.5%
Q1 FY2025Mar 31, 2025$2.21M-5.8%
Q4 FY2024Dec 31, 2024$3.51M+52.6%
Q3 FY2024Sep 30, 2024$3.11M+10.5%
Q2 FY2024Jun 30, 2024$2.72M+5.6%
Q1 FY2024Mar 31, 2024$2.35M-15.2%
Q4 FY2023Dec 31, 2023$2.30M-27.4%
Q3 FY2023Sep 30, 2023$2.81M+223.7%
Q4 FY2020Dec 31, 2020$2.58M+70.9%
Q3 FY2020Sep 30, 2020$2.77M+185.0%
Q2 FY2020Jun 30, 2020$3.17M+85.6%
Q1 FY2020Mar 31, 2020$869.00K-45.3%
Q4 FY2019Dec 31, 2019$1.51M-5.6%
Q3 FY2019Sep 30, 2019$973.00K-14.1%
Q2 FY2019Jun 30, 2019$1.71M+10.6%
Q1 FY2019Mar 31, 2019$1.59M+44.5%
Q4 FY2018Dec 31, 2018$1.60M+78.0%
Q3 FY2018Sep 30, 2018$1.13M+37.7%
Q4 FY2017Dec 31, 2017$1.54M+5240.0%
Q3 FY2017Sep 30, 2017$1.10M+2084.8%
Q2 FY2017Jun 30, 2017$896.52K+3613.4%
Q1 FY2017Mar 31, 2017$822.41K–
Q4 FY2016Dec 31, 2016$28.88K–
Q3 FY2016Sep 30, 2016$50.36K–
Q2 FY2016Jun 30, 2016$24.14K–

More Jaguar Health figures

See a number that looks wrong?